Literature DB >> 11412871

Cardiovascular autonomic control in Becker muscular dystrophy.

G Vita1, R Di Leo, C De Gregorio, A Papalia, C Rodolico, S Coglitore, C Messina.   

Abstract

Although autonomic symptoms are not prominent in dystrophinopathies, a reduced vagal activity and an enhanced sympathetic tone have been found in Duchenne muscular dystrophy. Twenty patients with Becker muscular dystrophy (BMD) were investigated by a battery of six cardiovascular autonomic tests (beat-to-beat variability during quiet breathing and deep breathing, heart rate responses to Valsalva maneuver and standing, blood pressure responses to standing and sustained handgrip) and power spectral analysis (PSA) of heart rate variability. Although 11 patients revealed abnormal findings at some cardiovascular tests, none of them had a definite autonomic damage, as indicated by two or more abnormal tests. The mean results of the single tests did not differ from normal controls, except for the beat-to-beat variability during quiet breathing, which was significantly higher in BMD (p<0.05). Such finding was confirmed by a significantly higher total variance (p<0.05), indicating an increased parasympathetic activity. Spectral components were not significantly different from normal controls. PSA values were not influenced by age, functional ability score or presence of heart abnormalities. Our data suggest that autonomic involvement does not represent a major finding in BMD.

Entities:  

Mesh:

Year:  2001        PMID: 11412871     DOI: 10.1016/s0022-510x(01)00500-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

Review 2.  Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies.

Authors:  L Politano; A Palladino; G Nigro; M Scutifero; V Cozza
Journal:  Acta Myol       Date:  2008-12

Review 3.  Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.

Authors:  Rita Wen Kaspar; Hugh D Allen; Federica Montanaro
Journal:  J Am Acad Nurse Pract       Date:  2009-05

4.  Angiotensin-dependent autonomic dysregulation precedes dilated cardiomyopathy in a mouse model of muscular dystrophy.

Authors:  Rasna Sabharwal; Robert M Weiss; Kathy Zimmerman; Oliver Domenig; Michael Z Cicha; Mark W Chapleau
Journal:  Exp Physiol       Date:  2015-06-15       Impact factor: 2.969

5.  A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy.

Authors:  Hugh D Allen; Kevin M Flanigan; Philip T Thrush; Igor Dvorchik; Han Yin; Charles Canter; Anne M Connolly; Mark Parrish; Craig M McDonald; Elizabeth Braunlin; Steven D Colan; John Day; Basil Darras; Jerry R Mendell
Journal:  PLoS Curr       Date:  2013-12-12

6.  Quantitative assessment of sitting time in ambulant adults with Muscular Dystrophy.

Authors:  Matthew F Jacques; Gladys L Onambele-Pearson; Bryn Edwards; Christian G De Goede; Christopher I Morse
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

7.  Autonomic regulation in muscular dystrophy.

Authors:  Corrado Angelini; Rita Di Leo; Paola Cudia
Journal:  Front Physiol       Date:  2013-09-20       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.